FDA Adverse Event Malfunction Summary report: N

SYR 3ML 22GA 1-1/4IN JPK/SIL NO ASSY NDL

MDR report key: 8692987 · Received June 12, 2019

Report

Report Number
9614033-2019-00162
Event Type
Malfunction
Date Received
June 12, 2019
Date of Event
May 23, 2019
Report Date
June 18, 2019
Manufacturer
BECTON DICKINSON DE MEXICO
Product Code
FMF
PMA / PMN Number
N/A
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MX
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION: PHOTOGRAPH AND PHYSICAL SAMPLE ARE RECEIVED FOR INVESTIGATION. UPON EVALUATION, A SYRINGE WITH MULTIPLE UNITS IN A PACKAGE (ASSEMBLED NEEDLES) ARE OBSERVED. THE LOT WAS INSPECTED ACCORDING TO THE CURRENT WORK INSTRUCTION WITH SATISFACTORY RESULTS FOR THE CHARACTERISTICS REQUIRED FOR ITS APPROVAL INCLUDING FUNCTIONAL TESTS. NO NON-CONFORMING PART THAT COULD BE ATTRIBUTABLE TO THE DEFECT REPORTED BY THE CLIENT WAS PRESENTED. NO DEVIATIONS (QUALITY NOTIFICATIONS) WERE REPORTED DURING THE MANUFACTURING PROCESS. THE DEFECT CAN BE GENERATED DURING MANUFACTURING BY FAILURE IN THE ASSEMBLED NEEDLE FEEDER.

Description of Event or Problem · 0

IT WAS REPORTED THAT DAMAGE OCCURRED WITH A SYR 3ML 22GA 1-1/4IN JPK/SIL NO ASSY NDL. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, "DOUBLE NEEDLE EXPOSED." 574 OCCURRENCES REPORTED BEFORE USE.

Additional Manufacturer Narrative · 1

(B)(6). A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED THAT DAMAGE OCCURRED WITH A SYR 3ML 22GA 1-1/4IN JPK/SIL NO ASSY NDL. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, "DOUBLE NEEDLE EXPOSED." 574 OCCURRENCES REPORTED BEFORE USE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
484294 SYR 3ML 22GA 1-1/4IN JPK/SIL NO ASSY NDL SYRINGE FMF BECTON DICKINSON DE MEXICO 9015772

Patients

Seq Age Sex Outcome Treatment
1 Other